Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate.
Nakashima Y, Kondo M, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Nagamine R, Nakashima H, Otsuka T, Saikawa I, Shono E, Suematsu E, Tsuru T, Wada K, Iwamoto Y. Nakashima Y, et al. Among authors: wada k. Mod Rheumatol. 2010 Aug;20(4):343-52. doi: 10.1007/s10165-010-0290-x. Epub 2010 May 18. Mod Rheumatol. 2010. PMID: 20480201
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: wada k. Mod Rheumatol. 2013 Apr 8. doi: 10.1007/s10165-013-0878-z. Online ahead of print. Mod Rheumatol. 2013. PMID: 23563508
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: wada k. Mod Rheumatol. 2014 Mar;24(2):258-64. doi: 10.3109/14397595.2013.854069. Mod Rheumatol. 2014. PMID: 24593201 Clinical Trial.
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.
Nakashima Y, Kondo M, Shono E, Ishinishi T, Tsukamoto H, Kuroda K, Maeyama A, Harada H, Maekawa M, Shimauchi T, Nagamine R, Jojima H, Yoshizawa S, Tsuru T, Otsuka T, Miyahara H, Suematsu E, Wada K, Yoshizawa S, Inoue Y, Fukuda T, Ikemura S, Haraguchi A. Nakashima Y, et al. Among authors: wada k. Mod Rheumatol. 2020 Sep;30(5):807-815. doi: 10.1080/14397595.2019.1676369. Epub 2019 Oct 17. Mod Rheumatol. 2020. PMID: 31580188
Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production.
Yamada H, Tsuru T, Otsuka T, Maekawa M, Harada H, Fukuda T, Tsukamoto H, Maeyama A, Yoshizawa S, Wada K, Nakashima Y, Shono E, Yoshizawa S, Jojima H, Kondo M. Yamada H, et al. Among authors: wada k. Immunol Med. 2020 Jun;43(2):87-91. doi: 10.1080/25785826.2020.1718833. Epub 2020 Jan 29. Immunol Med. 2020. PMID: 31994996 Free article.
The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Miszczyk M, Fazekas T, Schulz RJ, Mancon S, Litterio G, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Rajwa P, Wada K, Karakiewicz PI, Araki M, Shariat SF. Tsuboi I, et al. Among authors: wada k. Clin Genitourin Cancer. 2024 Dec;22(6):102237. doi: 10.1016/j.clgc.2024.102237. Epub 2024 Oct 17. Clin Genitourin Cancer. 2024. PMID: 39546952 Free article. Review.
Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study.
Wada N, Murakami T, Fauzi M, Sakaki K, Oshima S, Shimada Y, Asai K, Oshima A, Nomura S, Joo E, Mori M, Fujiwara R, Shide K, Wada K, Yabe D, Inagaki N, Harada N. Wada N, et al. Among authors: wada k. J Clin Med Res. 2024 Oct;16(10):503-508. doi: 10.14740/jocmr6031. Epub 2024 Oct 30. J Clin Med Res. 2024. PMID: 39544328 Free PMC article.
Body mass index and breast cancer risk in premenopausal and postmenopausal East Asian women: a pooled analysis of 13 cohort studies.
Wada K, Kuboyama K, Abe SK, Rahman MS, Islam MR, Saito E, Nagata C, Sawada N, Tamakoshi A, Shu XO, Sakata R, Hozawa A, Kanemura S, Ito H, Sugawara Y, Park SK, Kweon SS, Ono A, Kimura T, Wen W, Oze I, Shin MH, Shin A, Kim J, Lee JE, Matsuo K, Rothman N, Qiao YL, Zheng W, Boffetta P, Inoue M. Wada K, et al. Breast Cancer Res. 2024 Nov 14;26(1):158. doi: 10.1186/s13058-024-01907-5. Breast Cancer Res. 2024. PMID: 39543702 Free PMC article.
3,563 results